Alteryx (NYSE:AYX) Stock a Buy: Big Data and Big Growth Potential

The corporate world is treating data like gold these days. Just look at all of the companies in the cloud-computing and data analytics space and how their stocks have performed this year to see what the market thinks of the industry’s potential. Many companies are moving into the digital age at an accelerated pace due to the current circumstances surrounding the pandemic and need a way to figure out what to do with all of their data. This is one of the big reasons why Alteryx Inc (NYSE: AYX) stock has been performing so well.

Try to imagine the difficulties related to analyzing data for a company that just moved into the cloud. Not only do they have to find an efficient way to gather their data, but they also need to determine how to clean up that data so that they are able to make business decisions that benefit the company. Alteryx makes that possible with its “Analytic Process Automation” platform and the company has a lot of growth potential as we move further into the digital age.

Solving an Important Problem

If you aren’t familiar with data analytics, it essentially means finding a way to analyze raw data so that you are able to draw conclusions and use that information to your advantage. Every company with a large enterprise system and thousands of customers needs a way to figure out what to do with all of their raw data. Just imagine the difficulties in trying to figure out how to create actionable insights from massive amounts of data related to products, customers, and internal operations. This is where Alteryx comes into play.

Alteryx is the only end-to-end data analytics platform that helps data scientists gather, manage, and analyze their data all in one place. A big plus is that it helps data workers automate some of the more monotonous tasks in their jobs so that they can focus on more important value-added work. The platform helps discover and examine data so that companies are able to improve their performance in a variety of ways. When you think about the sheer amount of data that major companies have to deal with these days, it’s easy to understand the need for a platform that helps them make sense of it all.


New U.S. Marijuana legislation coupled with an increase in medicinal applications and presidential candidates pushing for additional approval have pushed Marijuana demand sky high. Don’t miss your opportunity to take advantage of this monumental reversal in Marijuana prohibition. Reserve your FREE copy of “The Top 5 Cannabis Stocks that Belong on Your Watchlist”.

Huge Sales and Revenue Growth

It can be difficult to value a young growth company like Alteryx, which is why many investors focus on top-line growth versus the bottom line. Although the company reported a net loss in Q1, its top-line growth was impressive. Alteryx reported year-over-year revenue growth of 43% to $108.8 million in Q1 2020 and an industry-leading 88% gross margin which are both numbers that investors should be excited about. You also have to keep in mind that Alteryx is investing heavily in the sales and development of its platform at this time.

Alteryx has been steadily adding new clients to its recurring revenue base and reported that it gained 356 net new customers in Q1. The company currently serves 37% of companies in the Global 2000, which means they still have room to grow their customer base considerably by targeting large corporations. Some of its well-known customers include Coca-Cola, P&G, Home Depot, and Wal-Mart, which tells us that the largest and most successful corporations in the world need help with managing their data with Alteryx’s platform.

Possible Volatility

It’s hard to deny the fact that Alteryx has a compelling product and strong top-line growth, but you also need to keep in mind that most of these new-age enterprise software companies have been skyrocketing this year and might need to cool off for a bit. Q2 earnings could also end up being a mixed bag for this company since its management provided weak guidance during the Q1 earnings release. A lot of companies that Alteryx targets are holding back spending in order to weather the financial storm occurring with Covid-19, which means that Alyterx’s sales cycle could be negatively affected in the near-term.

It seems that the market is pricing in something close to perfection for the company’s Q2 earnings, which is why there could be some possible volatility for the stock in the coming weeks. With that said, adding shares of Alteryx if the stock dips into the $150s could pay off handsomely in the long-term since the company has such a promising platform that can solve a big problem for companies in the digital age.

Companies Mentioned in This Article

13 Stocks Institutional Investors Won’t Stop Buying

University endowments, pension funds, sovereign wealth funds, hedge funds and other institutional investors have recently been pouring money into a a group of 13 elite stocks.

These institutional investors don’t get easily swayed by hot stocks that are popular with retail investors. You probably won’t see a Tesla or a SnapChat in this group, because institutional investors know that these “popular kid” stocks almost always aren’t great investments. However, you will find some incredibly solid companies on this list backed by real earnings and real fundamentals.

In order to identify these stocks, we had to comb through every 13D and 13F filing that institutional investors have filed with the SEC in the last quarter. After reviewing more than 5,000 filings, we have identified 13 companies that institutional investors have been buying left. Big money investors are pouring hundreds of millions of dollars into these stocks.

View the “13 Stocks Institutional Investors Won’t Stop Buying”.

(Excerpt) Read more Here | 2020-07-08 17:34:29
Image credit: source


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.